Haemonetics (HAE) Operating Expenses (2009 - 2026)

Haemonetics has reported Operating Expenses for 18 years, with the latest figure at $221.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 81.77% year-over-year to $221.2 million; the trailing twelve-month figure through Mar 2026 stood at $630.9 million (up 19.67% YoY), and the FY2026 full-year result was $630.9 million, up 19.67% from the prior year.
• Operating Expenses for Q1 2026 stood at $221.2 million, up from $135.0 million in the prior quarter.
• The five-year high for Operating Expenses was $221.2 million in Q1 2026, with the low at $102.9 million in Q1 2022.
• Average Operating Expenses over 5 years is $131.3 million, with a median of $133.2 million recorded in 2023.
• Year-over-year, Operating Expenses dropped 16.61% in 2025 and soared 81.77% in 2026.
• Tracing HAE's Operating Expenses over 5 years: stood at $115.4 million in 2022, then gained by 14.26% to $131.9 million in 2023, then rose by 1.99% to $134.5 million in 2024, then advanced by 0.35% to $135.0 million in 2025, then soared by 63.89% to $221.2 million in 2026.
• The last three Operating Expenses figures came in at $221.2 million (Q1 2026), $135.0 million (Q4 2025), and $136.3 million (Q3 2025), per Business Quant data.

Peer Comparison